title: Nitric oxide facilitates vagal control of heart rate via actions in the cardiac parasympathetic ganglia of the anaesthetised dog.
abstract: The effects of neuronal inhibition of nitric oxide (NO) production on the bradycardia resulting from stimulation of preganglionic and postganglionic parasympathetic fibres were investigated in an anaesthetised dog preparation following transection of the cervical vagi and in the presence of a beta-adrenoreceptor antagonist. Injection of 1-(2-trifluoromethylphenyl) imidazole (TRIM), an inhibitor of neuronally released NO, into the sinus node artery reduced the bradycardia evoked by right cervical vagal stimulation. In contrast, when the response to preganglionic stimulation had been abolished by hexamethonium (10 mg kg(-1)), the bradycardia following stimulation of postganglionic parasympathetic fibres on the atrial epicardium was unaffected by TRIM. First, these results confirm the facilitatory actions of neuronally released NO on vagal heart responses in the dog. Second, they indicate that this modulatory and facilitatory role of NO is likely to be exerted at vagal preganglionic-postganglionic synaptic mechanisms in the cardiac parasympathetic ganglia and not at the postganglionic-sinoatrial node synapse.
authors.affiliation: Department of Physiology, University College Cork, Cork, Ireland, UK. hazim@ucc.ie
authors.forename: F
authors.initials: F
authors.lastname: Markos
authors.forename: H M
authors.initials: HM
authors.lastname: Snow
authors.forename: C
authors.initials: C
authors.lastname: Kidd
authors.forename: K
authors.initials: K
authors.lastname: Conlon
mesh_terms: D000758:Anesthesia; D000818:Animals; D001919:Bradycardia / Q000139:chemically induced / Q000503:physiopathology; D004285:Dogs; D004562:Electrocardiography; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005726:Ganglia, Parasympathetic / Q000502:physiology*; D005730:Ganglionic Blockers / Q000494:pharmacology; D006321:Heart / Q000294:innervation* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects / Q000502:physiology*; D018738:Hexamethonium / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000378:metabolism; D052248:Nitric Oxide Synthase Type I; D012849:Sinoatrial Node / Q000294:innervation; D014630:Vagus Nerve / Q000502:physiology*
chemical_list: D004791:Enzyme Inhibitors; D005730:Ganglionic Blockers; D007093:Imidazoles; C098186:1-(2-trifluoromethylphenyl)imidazole; D009569:Nitric Oxide; D018738:Hexamethonium; D019001:Nitric Oxide Synthase; D052248:Nitric Oxide Synthase Type I